Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. | 82,986 | reported | 21 Aug 2018 | tx 9+538,062−11,698 |
| Keenova Therapeutics plc | 54,714 | reported | 31 Jul 2025 | tx 17+404,294−385,500 |
| Recro Pharma, Inc. | 0 | reported | 08 Apr 2024 | tx 24+579,333−445,309 |
| Aclaris Therapeutics, Inc. | 0 | reported | 01 Jun 2024 | tx 20+133,714−28,732 |
| IMPAX LABORATORIES INC | 0 | reported | 04 May 2018 | tx 37+391,012−382,917 |
1 purchase reported after at least 12 months of silence — most recent on 28 Aug 2023.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jul 2025 | GRANT_AWARD | Keenova Therapeutics plc | 41,035 | 0.00 USD | deriv |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 6,838 | — | |
| 01 Jan 2025 | TAX_WITHHOLDING | Keenova Therapeutics plc | 1,724 | — | |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 6,838 | 0.00 USD | deriv |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | — | |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 08 Apr 2024 | TENDER | Recro Pharma, Inc. | 217,429 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 73,620 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 27,229 | — | deriv |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 118,182 | — | deriv |
| 02 Feb 2024 | GRANT_AWARD | Keenova Therapeutics plc | 20,517 | 0.00 USD | deriv |
| 14 Nov 2023 | OTHER | Keenova Therapeutics plc | 96,660 | 0.00 USD | |
| 28 Aug 2023 | PURCHASE | Recro Pharma, Inc. | 62,500 | 0.40 USD | first after silence |
| 17 Aug 2023 | TAX_WITHHOLDING | Keenova Therapeutics plc | 15,976 | 0.69 USD | |
| 30 Jun 2023 | OTHER | Keenova Therapeutics plc | 168,237 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | — | |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 73,620 | — | |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 27,229 | 0.00 USD | deriv |
| 03 Apr 2023 | GRANT_AWARD | Keenova Therapeutics plc | 168,237 | 0.00 USD | deriv |
| 14 Dec 2022 | GRANT_AWARD | Keenova Therapeutics plc | 112,636 | 0.00 USD | |
| 16 Jun 2022 | OTHER | Keenova Therapeutics plc | 11,593 | 0.00 USD | |
| 16 Jun 2022 | OTHER | Keenova Therapeutics plc | 57,569 | 0.00 USD | deriv |